New Delhi: In a landmark development for Atmanirbhar Bharat, the government on Wednesday launched India’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease (SCD), particularly affecting the country’s tribal population. The therapy, named “BIRSA 101” in honour of tribal freedom fighter Bhagwan Birsa Munda, was unveiled by Union Minister of State (Independent Charge) for Science and Technology.

Described as “precise genetic surgery,” the therapy can not only cure SCD but also transform treatment for other hereditary disorders, the Minister said. SCD, a chronic single-gene disorder, leads to severe anaemia, painful episodes, organ damage, and reduced life expectancy.

Dr. Singh stated, “India has formally begun its decisive journey towards becoming a Sickle Cell Disease–free

See Full Page